![ELOCTATE® (Antihemophilic Factor Recombinant), Fc Fusion Protein]](/Content/images/eloctate-logo.svg){kind=logo}
financial assistance
HemAssist™ SANOFI SUPPORT
We surround ELOCTATE patients with access, support, and education from Sanofi throughout their treatment journey.
When you’re living with hemophilia, you may need support on your side. HemAssist provides people and their caregivers with the support they may need along their treatment journey. This includes:
Financial assistance
Every person’s situation is different, which is why we work directly with you to help identify the financial assistance programs for which you may be eligible.
Treatment education
We can help you understand more about treatment with ELOCTATE, as well as offer tips and supplemental infusion training.
Access to treatment
Our team works with you and your care team to verify your insurance coverage and get you started on treatment as efficiently as possible.
Financial assistance:
Copay Assistance Program*
If you have commercial insurance (insurance sponsored by your employer or private insurance) and you’re having trouble paying for ELOCTATE, HemAssist’s Copay Assistance Program may be able to help. Get ELOCTATE for as little as $0.
Free Trial Program†
If you’re prescribed ELOCTATE for the first time, you can get your first 30-day supply of treatment generally within 24 to 48 hours with a valid prescription from your healthcare provider.
Patient Assistance
Program†
HemAssist's Patient Assistance Program may be available to help eligible ELOCTATE patients who are uninsured, underinsured, or experiencing a temporary loss in insurance coverage.
*Not valid if the patient is utilizing a state or federally funded health insurance program such as Medicare (including Medicare Part D), Medicaid, Medigap, VA, DoD, TRICARE®, state pharmaceutical assistance program, etc., to pay in part or in full for their ELOCTATE prescription. Not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Copay Program at any time without notice. Savings by patients may vary depending on their out-of-pocket costs. The program is intended to help patients afford their ELOCTATE prescription. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms.
†Claims for free products dispensed through the Free Trial or Patient Assistance Programs shall not be submitted to any third-party payer, public or private (eg, private insurance, Medicaid, Medicare, VA, DoD, TRICARE®, or similar federal or state programs), for reimbursement. All Programs not valid where prohibited by law. Sanofi reserves the right to modify or terminate the Programs at any time without notice. Program details provided upon registration.
YOUR HemAssist TEAM MEMBERS:
Our dedicated HemAssist team is here to help.
We’ll work with you one-to-one to help you start and stay with treatment as prescribed.
Clinical Educators (CE)
Your dedicated Clinical Educator (CE) is your point of contact for questions and tips about ELOCTATE, supplemental infusion training, and ongoing support.
Your CE will not provide personal medical advice. For all questions about your individual health needs, consult with your treating physician.
Case Manager
Your Case Manager is available to assist with navigating insurance coverage and identifying available financial support for eligible patients.
COMMUNITY RELATIONS AND
EDUCATION MANAGER (CoRe)
CoRes are dedicated to providing education and empowering those within the hemophilia community through one-to-one communication, as well as through community events and conferences.
Support is on your side
Learn more about the Sanofi support available to you from HemAssist.
Visit SanofiHemAssist.com
CONTACT YOUR CoRe
Sanofi Hemophilia Community Relations and Education (CoRe) Managers offer education to people living with hemophilia and their families. CoRe Managers provide information about living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe team member nearest you.
Get informed. Stay informed.
Let's stay in touch. We'll occasionally send you important information on Hemophilia A and ELOCTATE.
LET'S GET STARTEDELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
IMPORTANT SAFETY INFORMATION AND INDICATION
+
IMPORTANT SAFETY INFORMATION
Do not use ELOCTATE if you have had an allergic reaction to it in the past.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.
Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.
If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.
These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.
INDICATION
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
PLEASE SEE FULL PRESCRIBING INFORMATIONMANUFACTURED BY
Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078
CLICK HERE TO LEARN MORE ABOUT SANOFI'S COMMITMENT TO FIGHTING COUNTERFEIT DRUGS.
INDICATION
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
MAT-US-2021872-v8.0-08/2025 LAST UPDATED: AUGUST 2025